Lantheus Q2 FY26 GAAP EPS slips 0.9% to $1.11; revenue rises 2.7% to $388.2 million

• Lantheus posted Q2 worldwide revenue of $388.2 million, up 2.7% from a year earlier; GAAP diluted EPS edged down 0.9% to $1.11.
• GAAP net income slipped 4.7% to $75 million; operating income climbed 13.9% to $100.2 million.
• Adjusted diluted EPS (non-GAAP) fell 1.3% to $1.55; adjusted operating income (non-GAAP) declined 6.9% to $142 million.
• PYLARIFY sales dropped 4.1% to $240.4 million, while DEFINITY sales rose 5.2% to $88.3 million; Neuraceq contributed $39.6 million.
• Curium agreed to acquire all shares for $102.50 per share in cash, with CVRs worth up to $12 per share; full-year 2026 guidance was suspended.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lantheus Holdings Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.